Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: A possible contribution to bile duct fibrosis

Journal of Pathology

Volumn 189, Issue 4, 1999, Pages 609-614

  Tsuneyama, Koichi ^a   Kono, Naoko ^a   Yamashiro, Masashi ^a   Kouda, Wataru ^a   Sabit, Amura ^a   Sasaki, Motoko ^a   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

C kit; Hepatolithiasis; Intrahepatic biliary tree; Primary sclerosing cholangitis; Stem cell factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BILE DUCT DISEASE; BILE DUCT STONE; CELL INFILTRATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; EPITHELIUM CELL; FIBROGENESIS; FIBROSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAST CELL; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BILE DUCTS, INTRAHEPATIC; CHOLANGITIS, SCLEROSING; CHOLELITHIASIS; CHYMASES; EPITHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MAST CELLS; PROTO-ONCOGENE PROTEINS C-KIT; SERINE ENDOPEPTIDASES; STEM CELL FACTOR; TRYPTASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032721633     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199912)189:4<609::AID-PATH474>3.0.CO;2-2     Document Type: Article

References (34)

1. Nakanuma Y, Yamaguchi K, Ohta G, et al. Pathologic features of hepatolithiasis in Japan. Hum Pathol 1988; 9: 1181-1186.
2. Nakayama F. Intrahepatic stones: epidemiology and etiology. Prog Clin Biol Res 1984; 152: 17-28.
3. Maki T. Pathogenesis of calcium bilirubinate stone: role of E. coli, β-glucuronidase and coagulation by inorganic ions, polyelectrolytes and agitation. Ann Surg 1966; 164: 90-100.
4. Maki T, Nakamura N. Histochemical study on mucopolysaccharides in calcium stones. Tohoku J Exp Med 1969; 98: 81-86.
5. Kobayashi S, Nakanuma Y, Matsui O. Intrahepatic peribiliary vascular plexus in various hepatobiliary diseases: a histological survey. Hum Pathol 1994; 25: 940-946.
6. MacSween RNM, Anthony PP, Scheuer PJ, et al. Pathology of the Liver. Churchill Livingstone: Edinburgh, 1994; 477.
7. Yamashiro M, Kohda W, Kono N, et al. Distribution of intrahepatic mast cells in various hepatobiliary disorders. An immunohistochemical study. Virchows Arch 1998; 433: 471-479.
8. Omori M, Evarts RP, Omori N, et al. Expression of alpha-fetoprotein and stem cell factor/c-kit system in bile duct ligated young rats. Hepatology 1997; 25: 1115-1122.
9. Omori M, Omori N, Evarts RP, et al. Coexpression of flt-3 ligand/flt-3 and SCF/c-kit signal transduction system in bile-duct-ligated SI and W mice. Am J Pathol 1997; 150: 1179-1187.
10. Rioux KP, Sharkey KA, Wallace JL, et al. Hepatic mucosal mast cell hyperplasia in rats with secondary biliary cirrhosis. Gastroenterology 1996; 23: 888-895.
11. Ramos SG, Montenegro AP, Goissis G, et al. Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum-induced rat liver fibrosis. Pathol Int 1994; 44: 655-661.
12. Peng RY, Wang DW, Xu ZH, et al. The changes and significance of mast cells in irradiated rat liver. J Environ Pathol Toxicol Oncol 1994; 13: 111-116.
13. Inoue Y, King TE Jr, Tinkle SS, et al. Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorder. Am J Pathol 1996; 149: 2037-2054.
14. Armbrust T, Batusic D, Ringe B, et al. Mast cell distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis. J Hepatol 1997; 26: 1042-1054.
15. Palecanda A, Briskin MJ, Issekutz TB. Rat mast cell lines bind to the vascular cell adhesion molecule-I (VCAM-I) and the mucosal addressin cell adhesion molecule (MadCAM-I). J Immunol 1997; 158: 2904-2910.
16. Valent P, Spanblochl E, Sperr WR, et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 1992; 80: 2237-2245.
17. Thomas PS, Pennington DW, Schreck RE, et al. Authentic 17 kDa tumour necrosis factor alpha is synthesized and released by canine mast cells and upregulated by stem cell factor. Clin Exp Allergy 1996; 26: 710-718.
18. Lemura A, Tsai M, Ando A, et al. The c-kit ligand, stem cell factor, promote mast cell survival by suppressing apoptosis. Am J Pathol 1994; 144: 321-328.
19. Greenwel IP, Iraburu MJ, Reyes-Romero M, et al. Induction of an acute phase response in rats stimulates the expression of alpha I(I) procollagen messenger ribonucleic acid in their livers. Possible role of interleukin-6. Lab Invest 1995; 72: 83-91.
20. Tsukamoto H, Rippe R, Niemel O, et al. Roles of oxidative stress in activation of Kupffer and Ito cells in liver fibrogenesis. J Gastroenterol Hepatol 1995; 10: 50-53.
21. Kamimura S, Tsukamoto H. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 1995; 22: 1304-1309.
22. Saito H, Ebisawa M, Sakaguchi N, et al. Characterization of cord-blood-derived human mast cells cultured in the presence of Steel factor and interleukin-6. Int Arch Allergy Immunol 1995; 107: 63-65.
23. Nakanuma Y, Hoso M, Sanzen T, et al. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microsc Res Tech 1997; 38: 552-570.
24. Terasaki S, Nakanuma Y, Unoura M, et al. Involvement of peribiliary glands in primary sclerosing cholangitis: a histologic study. Intern Med 1997; 36: 766-770.
25. Matsumoto T, Matsumori H, Kuwabara N, et al. A histopathological study of the liver in paraquat poisoning. An analysis of fourteen autopsy cases with emphasis on bile duct injury. Acta Pathol Jpn 1980; 30: 859-870.
26. Mullick FG, Ishak KG, Mahabir R, et al. Hepatic injury associated with paraquat toxicity in humans. Liver 1981; 1: 209-221.
27. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-580.
28. Wood GS, Warnke R. Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection system. J Histochem Cytochem 1981; 29: 1196-1204.
29. Aoki J, Nanba K, Yamamoto T, et al. Multistaining method by using hot-bath treatment. Byori-to-Rinsho 1996; 14: 1533-1536 (in Japanese).
30. Hartmann K, Henz BM, Kruger-Krasagake S, et al. C3a and C5a stimulate chemotaxis of human mast cells. Blood 1997; 89: 2863-2870.
31. Hogaboam C, Kunkel SL, Strieter RM, et al. Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions. J Immunol 1998; 160: 6166-6170.
32. Meininger CJ, Yano H, Rottapel R, et al. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 1992; 79: 958-963.
33. Nilsson G, Butterfield JH, Nilsson K, et al. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994; 153: 3717-3723.
34. Nilsson G, Hjertson M, Andersson M, et al. Demonstration of mast-cell chemotactic activity in nasal lavage fluid: characterization of one chemotaxin as c-kit ligand, stem cell factor. Allergy 1998; 53: 874-879.